Without Acquisition, Acadia Healthcare Shares Remain Overvalued

Without acquisition hopes, the expectations baked into the current stock price remain unrealistically high. Specifically, to justify the current price of $55/share, ACHC must grow NOPAT by 14% compounded annually for the next 12 years.